CompaniesSLC Consulting

SLC Consulting

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

1

As Collaborator

8

Total Enrollment

338

By Phase

NA: 3EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE2: 2PHASE1: 2

By Status

COMPLETED: 5ACTIVE_NOT_RECRUITING: 3RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT05307874
NCT06293482
Hover over trial bars to see details

Recent Trials

NCT06598059Collaborator
Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array
NAActive, not recruiting
56 participants
Started: Jan 3, 2025 · Completed: Sep 30, 2026
NCT06293482Collaborator
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NAActive, not recruiting
50 participants
Started: Sep 17, 2024 · Completed: Oct 31, 2028
NCT06539637Lead Sponsor
Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
EARLY_PHASE1Recruiting
20 participants
Started: Sep 1, 2023 · Completed: Feb 28, 2026
NCT05307874Collaborator
Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
56 participants
Started: Apr 19, 2022 · Completed: Dec 31, 2025
NCT03794557Collaborator
The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD
PHASE2Completed
20 participants
Started: Jan 21, 2019 · Completed: Mar 23, 2021
View all 9 trials →